Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fakhro A. M., Ritchie R. F., Lown B. Lupus-like syndrome induced by procainamide. Am J Cardiol. 1967 Sep;20(3):367–373. doi: 10.1016/0002-9149(67)90060-4. [DOI] [PubMed] [Google Scholar]
- HOLLEY H. L. EVIDENCE FOR A PREDISPOSITION TO RHEUMATIC DISEASES IN FAMILIES OF PATIENTS DEVELOPING DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS. Arthritis Rheum. 1964 Dec;7:684–686. doi: 10.1002/art.1780070608. [DOI] [PubMed] [Google Scholar]
- LADD A. T. Procainamide-induced lupus erythematosus. N Engl J Med. 1962 Dec 27;267:1357–1358. doi: 10.1056/NEJM196212272672608. [DOI] [PubMed] [Google Scholar]
- Lee S. L., Rivero I., Siegel M. Activation of systemic lupus erythematosus by drugs. Arch Intern Med. 1966 May;117(5):620–626. [PubMed] [Google Scholar]
- McDevitt D. G., Glascow J. F. Lupus-like syndrome induced by procainamide. Br Med J. 1967 Sep 23;3(5568):780–781. doi: 10.1136/bmj.3.5568.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Siegel M., Lee S. L., Peress N. S. The epidemiology of drug-induced systemic lupus erythematosus. Arthritis Rheum. 1967 Oct;10(5):407–415. doi: 10.1002/art.1780100502. [DOI] [PubMed] [Google Scholar]
- Vischer T. L. Lymphocyte cultures in drug hypersensitivity. Lancet. 1966 Aug 27;2(7461):467–469. doi: 10.1016/s0140-6736(66)92773-5. [DOI] [PubMed] [Google Scholar]